Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2007-08-28
2007-08-28
Kim, Young J. (Department: 1637)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
Reexamination Certificate
active
10019514
ABSTRACT:
Nucleic acids can be made available for amplification or other treatment after admixture of a sample with specific weakly basic polymers to form a precipitate with the nucleic acids at acidic pH. After removing non-precipitated materials, the pH is then made basic, thereby releasing the nucleic acids from the polymer. This method for preparing specimen samples is simple and quite rapid, and the released nucleic acids can be further treated in hybridization assays or amplification procedures. No surfactant or other cell lysing reagents are employed. The weakly basic polymers are water-soluble and cationic at acidic pH, but neutral in charge at basic pH.
REFERENCES:
patent: 4089747 (1978-05-01), Bruschi
patent: 4683195 (1987-07-01), Mullis et al.
patent: 4683202 (1987-07-01), Mullis
patent: 4713326 (1987-12-01), Dattagupta et al.
patent: 4795698 (1989-01-01), Owen et al.
patent: 4889818 (1989-12-01), Gelfand et al.
patent: 4914210 (1990-04-01), Levenson et al.
patent: 4920061 (1990-04-01), Poynton et al.
patent: 4962029 (1990-10-01), Levenson et al.
patent: 4965188 (1990-10-01), Mullis et al.
patent: 4994373 (1991-02-01), Stavrianopoulos et al.
patent: 4997772 (1991-03-01), Sutton et al.
patent: 5118801 (1992-06-01), Lizardi et al.
patent: 5147777 (1992-09-01), Sutton et al.
patent: 5155166 (1992-10-01), Danielson et al.
patent: 5173260 (1992-12-01), Zander et al.
patent: 5229297 (1993-07-01), Schnipelsky et al.
patent: 5231015 (1993-07-01), Cummins et al.
patent: 5312728 (1994-05-01), Lizardi et al.
patent: 5334499 (1994-08-01), Burdick et al.
patent: 5338671 (1994-08-01), Scalice et al.
patent: 5380489 (1995-01-01), Sutton et al.
patent: 5434270 (1995-07-01), Ponticello et al.
patent: 5523368 (1996-06-01), Ponticello et al.
patent: 5582988 (1996-12-01), Backus et al.
patent: 5587287 (1996-12-01), Scalice et al.
patent: 5622822 (1997-04-01), Ekeze et al.
patent: 5683877 (1997-11-01), Lu-Chang et al.
patent: 5702884 (1997-12-01), Ekeze et al.
patent: 5925517 (1999-07-01), Tyagi et al.
patent: H-0 070 687 (1983-01-01), None
patent: A-0 308 236 (1989-03-01), None
patent: A-0 320 308 (1989-06-01), None
patent: A-0 393 744 (1990-10-01), None
patent: A-0 428 197 (1991-05-01), None
patent: A-0 439 182 (1991-07-01), None
patent: A-0 439 222 (1991-07-01), None
patent: A-0 487 218 (1992-05-01), None
patent: A-0 512 334 (1992-11-01), None
patent: A-0 408 738 (1994-01-01), None
patent: A-0 707 077 (1995-09-01), None
patent: 0 953 635 (1999-11-01), None
patent: 0 871 767 (2002-03-01), None
patent: A-2 327 497 (1999-01-01), None
patent: WO89/06691 (1989-07-01), None
patent: WO91/12342 (1991-08-01), None
patent: WO92/16659 (1992-10-01), None
patent: WO95/16792 (1995-06-01), None
patent: WO96/15262 (1996-05-01), None
patent: WO96/32500 (1996-10-01), None
patent: WO97/34015 (1997-09-01), None
patent: WO99/004037 (1999-01-01), None
patent: WO 01/49877 (2001-07-01), None
Gwynne et al., “Drug Discovery and Biotechnology Trends Genomes and Microbes: Resisting Drug Resistance,” online publication from www.sciencemag.org, publication date, May 9, 2003, pp. 1-8 (print out).
Manen e tal., “A fully automatable enzymatic method for DNA extraction from plant tissues,” BMC Plant Biology, vol. 5, No. 23, pp. 1-9.
Steinman, C.R., J. Clin. Invest. 56: 512-515, 1975.4.
Raptis, L. et al., J. Clin. Invest. 66:1391-1399, 1980.
Leon, S. A., et al., Cancer Res., 37: 646-650, 1977.
Stroun, M., et al., Eur. J. Cancer Clin. Oncol.28: 707-712, 1987.
Fournie, G. J., et al., Cancer Lett., 91: 221-227, 1995.
Lin, A., et al., BioTechniques 24: (6) 937-940, 1998.
Sorenson, G. D., et al., Cancer Epidemiology, Biomakers and Prevention 3:67-71., 1994.
Vasyukhin, V., et al.,InChallenges of Modern Medicine, vol. 5, Biotechnology Today R. Verna, and A. Shamoo, Eds, 141-150. Aera-Serono Symposia Publications, Rome.
Mulcahy, H. E., et al., Clin. Cancer Res., 4: 271-275., 1998.
Kopreski, M. S., et al., Brit. J. Cancer 76: 1293-1299, 1997.
Chen, X., et al., Nature Medicine 2: 1033-1035, 1996.
Vasioukin, V., et al., Brit. J. Haematology 86: 774-779, 1994.
Tada, M., et al., Cancer Res. 53: 2472-2474, 1993.
Lo Dennis, Y.M., et al., Am. J. Human Genet. 62: 768-775, 1998.
Laure, et al., The Lancet, pp. 538-540 (Sep. 3, 1988).
Maniatis, et al., Molecular Cloning: A Laboratory Manual, pp. 280-281 (1982).
Gross-Belland, et al., Eur. J. Biochem., 36,32 (1973).
Agrawal, et al., Nucleic Acid Res., 14, pp. 6227-45 (1986).
Anker, et al., Gastroenterology, 1997, vol. 112, No. 4, pp. 1114-1116.
Ferguson, W. J., et al., Analytical Biochemistry, 104, pp. 300-310 (1980).
Good, N. E., et al., Biochemistry, vol. 5., No. 2, pp. 467-477, Feb. 1966.
Good, N. E., and Izawa, S., Meth. Enzymol, 24, Part B. 53-68 (1972).
Supplementary Partial European Search Report, dated Mar. 5, 2004, for European Appln. No. EP 01 97 7871.
Sokol, Deborah L. et al., “Real Time Detection fo DNA-RNA Hybridization in Living Cells”, Proc. Nat'l. Acad. Sci., USA, vol. 95, pp. 11538-11543, Sep. 1998.
A;Hnen, D. J. , et al., Kl-rasMutation and p53 Overexpression Predict the Clinical Behavior of Colorectal Cancer: A Southwest Oncology Group Study.
Andreyev, H.J., et al., “Kirsten ras Mutations in Patients with Colorectal Cancer: the Multicenter “RASCAL” Study”, Natl. Cancer Inst., (1998), 90(9), 675-684.
Aoki, T., et al., “APCandp53Mutations in de Novo Colorectal Adenocarcinomas”, Hum. Mutat., (1994), 3(4):342-346.
Bos, J. L., et al., “Three Different Mutations in Codon 61 of the Human N-rasGene Detected by Synthetic Oligonucleotide Hybridization”, Nuclic Acids Res., (1984), 12(23):9155-9163.
Bos, J. L. et al., “Prevalence ofrasGene Mutations in Human colorectal Cancers”, Nature (1987), 327(6120):293-297.
Bos, J. L. et al., “ResOncogenes in Hematopoietic Malignancies”, Hematol. Pathol., (1988), 2:55-63.
Bos, J. L., “TherasGene Family and Human Carcinogenesis”, Mutat. Res., (1988), 195:255-271.
Bos, J. L., “rasOncogenes in Human Cancer: A Review”, Can. Res., (1989), 49:4682-4689.
Calaluce, R., et al., “Micrometastasis in Colorectal Carcinoma: A Review”, J. Surg. Oncol., (1998), 67:194-202.
Capon, D. J., et al., “Activation of Kl-ras2 Gene in Human Colon and Lung Carcinomas By Two Different Point Mutations”, Nature, (1983), 302:33-37.
Castells, Antoni, et al., “K-rasMutations in DNA Extracted From the Plasma of Patients with Pancreatic Carcinoma: Diagnostic Utility and Prognostic Significance”, Journal of Clinical Oncology (1999), 17(2), 578-584.
Cohen, J. B., et al., “A Point Mutation in the Last Intron Responsible for Increased Expression and Transforming Activity of the c-Ha-rasOncogene”, Nature, (1988), 334(6178):119-124.
Dukes, C. E., “The Cliaffication of Cancer of the Rectum”, J. Pathol. Bacteriol., (1932), 35:323-332.
Findlay, J. B., et al., “Automated Closed-Vessel System for In Vitro Diagnostics Based on Polymerase Chain Reaction”, Clin. Chem., (1993), 39(9):1927-1933.
Fuery, C. J., et al., “Detection of Rare Mutant Alleles by Restriction Endonuclease-Mediated Selective-PCR: Assay Design and Optimization”, Clin. Chem., (2000), 46(5):620-624.
Haliassos, A., et al., “H-rasOncogene Mutations in the Urine of Patients with Bladder Tumors: Description of Non-Invasive Method for the Detection of Neoplasia”, Int. J. Oncol., (1992), 1:731-734.
Hayashi, N et al., “Generic Diagnosis Identifies Occult Lymph Node Metastases Undetectable by the Histopathological Method”, Cancer Res., (1994), 54:3853-3856.
Hayashi, N., et al., “Genetic Diagnosis of Lymph-Node Metastasis in Colorectal Cancer”, Lancet, (1995), 345:1257-1259.
Maebo, A., “Plasma DNA Level as a Tumor Marker In Primary Lung Cancer”, Nihon Kyobu Shikkan Gakkai Zasshi, (1990), 28(8), 1085-91.
Moertel, C. G., et al., “Levamisole and Fluorouracil for Adjuvant Therapy of Resected Colon Carcinoma”, Clin. Cancer Res., (1
Belly Robert T.
Sun Jianbo
Gowen Catherine K.
Kim Young J.
Ortho-Clinical Diagnostics, Inc.
LandOfFree
Rapid and efficient capture of DNA from sample without using... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Rapid and efficient capture of DNA from sample without using..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Rapid and efficient capture of DNA from sample without using... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3847939